- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 311/19 - Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
Patent holdings for IPC class C07C 311/19
Total number of patents in this class: 151
10-year publication summary
10
|
11
|
9
|
13
|
9
|
9
|
10
|
7
|
5
|
6
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Governing Council of The University of Toronto, | 1478 |
7 |
Molecular Insight Pharmaceuticals, Inc. | 55 |
6 |
Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | 823 |
5 |
Navitor Pharmaceuticals, Inc. | 32 |
5 |
H. Lee Moffitt Cancer Center and Research Institute, Inc. | 951 |
4 |
The University of Melbourne | 536 |
4 |
University of Alcala de Henares | 5 |
4 |
Novartis AG | 10829 |
3 |
University of South Florida | 1832 |
3 |
Cornell University | 3307 |
3 |
Ligand Pharmaceuticals Incorporated | 169 |
3 |
University of Central Florida Research Foundation, Inc. | 1186 |
3 |
South Rampart Pharma, LLC | 3 |
3 |
Centessa Pharmaceuticals (UK) Limited | 47 |
3 |
Boehringer Ingelheim International GmbH | 4644 |
2 |
Duke University | 3067 |
2 |
Northwestern University | 3400 |
2 |
The Brigham and Women's Hospital, Inc. | 2186 |
2 |
Epizyme, Inc. | 373 |
2 |
Georgia State University Research Foundation, Inc. | 344 |
2 |
Other owners | 83 |